^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    varnimcabtagene autoleucel (ARI-0001)

    i
    Other names: ARI-0001, PEI 19-187, CART19, adult differentiated autologous T-cells transducted with a lentivirus to express a chimeric antigen receptor with anti-CD19 specificity [A3B1] conjugated to the 4-aBB and CD3z, IMN-003A
    Company:
    August Pi i Sunyer Biomedical Research Institute, Immuneel Therap
    Drug class:
    CD19-targeted CAR-T immunotherapy
    Related drugs: